权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Core 1: Administration

核心 1：管理

基本信息

批准号：
10631158
负责人：
HAIAN FU
金额：
$ 15.94万
依托单位：
EMORY UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-06-01 至 2027-05-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10631158
关键词：
Advocate Award Basic Cancer Research Bioinformatics Biology Biostatistics Core Cancer Center Clinical Investigator Clinical Trials Collaborations Communication Consultations Data Decision Making Ensure Ethics Evaluation Evaluation Research Funding Future Goals Grant Human Resources Immunotherapy Individual Institution Interdisciplinary Study Leadership Lung Adenocarcinoma Maintenance Malignant neoplasm of lung Monitor National Cancer Institute Office of Administrative Management Patients Performance Policies Preparation Procedures Productivity Program Research Project Grants Progress Reports Quality Control Recommendation Regulation Reporting Research Resistance Resource Sharing Resources STK11 gene Schedule Science Strategic Planning Therapeutic Training Translating United States National Institutes of Health Universities clinical translation data quality experience experimental study improved interdisciplinary approach lectures meetings member operation programs quality assurance recruit remediation success symposium

项目摘要

SUMMARY Vital to the success of the Lung Cancer P01, the overall goal of the Administrative Core is to provide leadership and coordination of all scientific activities, as well as fiscal management and general administrative activities in order to maximize the integrated performance of the Emory University Lung Cancer P01. The Administrative Core will be led by Drs. Haian Fu, Suresh Ramalingam and Adam Marcus, whose varied experience and expertise in the successful and productive management of individual and large multi- disciplinary research programs combines the perspectives of a basic research cancer pharmacologist with a translational clinical investigator and an expert in LKB1 biology in order to streamline and ensure high-quality decision-making for the P01. The Administrative Core will provide three distinct specific functions: (1) administration (2) coordination (3) monitoring and implementation. Administrative functions will include oversight of all Project and Core activities, fiscal oversight, provision of the necessary resources, acquisition and allocation of institutional support, preparation of annual progress reports and other documents. Coordination functions will include planning and scheduling of monthly program meetings and regular advisory board meetings, engagement of advisory board members including patient advocates, coordination of interactions between Projects, Cores and between the P01 and the Cancer Center, communication and consultation with NCI project officer and staff, organization of P01-sponsored lectures and symposia. Monitoring and implementation will include regular tracking and evaluation of research progress and data quality for all projects and cores, implementation of advisors’ recommendations, remediation of under-performing projects, and assuring compliance with all governmental, NCI, and local regulations and requirements. Guided by the P01 Executive Committee, comprised of Program, Project and Core leaders, as well as engaged advisory boards, the Administrative Core will facilitate intra-programmatic collaborations and integration of the projects and cores to result in a unified multidisciplinary approach focused on exploiting our improved understanding of LKB1-associated immunotherapy resistance in lung adenocarcinoma and translating these studies into current and future therapeutic opportunities.

总结